(Q38559266)

4 September 2017

1 reference

title

Recombinant Newcastle disease virus-vectored vaccines against human and animal infectious diseases (English)

1 reference

4 September 2017

0 references

1 reference

Newcastle disease virus

object named as

Newcastle disease virus

1 reference

Zhiqiang Duan

1

1 reference

4 September 2017

Houqiang Xu

series ordinal

2

1 reference

4 September 2017

Xinqin Ji

series ordinal

3

1 reference

4 September 2017

Jiafu Zhao

series ordinal

4

1 reference

4 September 2017

language of work or name

1 reference

3 August 2015

1 reference

4 September 2017

number of pages

17

1 reference

based on heuristic

inferred from page(s)

published in

Future Microbiology

1 reference

4 September 2017

volume

10

1 reference

4 September 2017

issue

8

1 reference

4 September 2017

page(s)

1307-1323

1 reference

Overview of vaccines and vaccination

4 September 2017

cites work

1 reference

Making vaccines "on demand": a potential solution for emerging pathogens and biodefense?

21 January 2018

1 reference

The decision making process on new vaccines introduction in South Africa

21 January 2018

1 reference

Technologies for the development of West Nile virus vaccines

21 January 2018

1 reference

Issues in the design and implementation of vaccine trials in less developed countries

21 January 2018

1 reference

Vaccines: A review of immune-based interventions to prevent and treat disease

21 January 2018

1 reference

Optimizing vaccine development

21 January 2018

1 reference

Recombinant viruses as vaccines against viral diseases

21 January 2018

1 reference

Virus-vectored influenza virus vaccines

21 January 2018

1 reference

Vector-mediated antibody gene transfer for infectious diseases

21 January 2018

1 reference

A host-restricted viral vector for antigen-specific immunization against Lyme disease pathogen.

21 January 2018

1 reference

Newcastle disease virus: current status and our understanding

21 January 2018

1 reference

Recombinant Newcastle disease virus as a vaccine vector

21 January 2018

1 reference

Recombinant Newcastle disease virus as a vaccine vector.

21 January 2018

1 reference

Newcastle disease virus: a promising vector for viral therapy, immune therapy, and gene therapy of cancer

21 January 2018

1 reference

Newcastle disease: evolution of genotypes and the related diagnostic challenges

21 January 2018

1 reference

A summary of taxonomic changes recently approved by ICTV.

21 January 2018

1 reference

Sequence variation in the Newcastle disease virus genome

21 January 2018

1 reference

Newcastle disease virus: macromolecules and opportunities

21 January 2018

1 reference

Transcriptive complex of Newcastle disease virus. I. Both L and P proteins are required to constitute an active complex

21 January 2018

1 reference

Transcriptive complex of Newcastle disease virus. II. Structural and functional assembly associated with the cytoskeletal framework

21 January 2018

1 reference

Requirements for the assembly and release of Newcastle disease virus-like particles

21 January 2018

1 reference

Mutations in the FPIV motif of Newcastle disease virus matrix protein attenuate virus replication and reduce virus budding

21 January 2018

1 reference

Viral entry mechanisms: the increasing diversity of paramyxovirus entry

21 January 2018

1 reference

RNA sequence and transcriptional properties of the 3' end of the Newcastle disease virus genome

21 January 2018

1 reference

Nucleotide sequences of the trailer, nucleocapsid protein gene and intergenic regions of Newcastle disease virus strain Beaudette C and completion of the entire genome sequence

21 January 2018

1 reference

Reverse genetics of negative-stranded RNA viruses: a global perspective

21 January 2018

1 reference

A decade after the generation of a negative-sense RNA virus from cloned cDNA - what have we learned?

21 January 2018

1 reference

Generation of recombinant lentogenic Newcastle disease virus from cDNA.

21 January 2018

1 reference

Recovery of a virulent strain of newcastle disease virus from cloned cDNA: expression of a foreign gene results in growth retardation and attenuation

21 January 2018

1 reference

Virulence of Newcastle disease virus is determined by the cleavage site of the fusion protein and by both the stem region and globular head of the haemagglutinin-neuraminidase protein

21 January 2018

1 reference

Generation of a velogenic Newcastle disease virus from cDNA and expression of the green fluorescent protein

21 January 2018

1 reference

Generation of a genotype VII Newcastle disease virus vaccine candidate with high yield in embryonated chicken eggs

21 January 2018

1 reference

Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase

21 January 2018

1 reference

Rescue of Newcastle disease virus from cloned cDNA using an RNA polymerase II promoter

21 January 2018

1 reference

Recovery of avirulent, thermostable Newcastle disease virus strain NDV4-C from cloned cDNA and stable expression of an inserted foreign gene

21 January 2018

1 reference

Development of a reverse genetics system based on RNA polymerase II for Newcastle disease virus genotype VII.

21 January 2018

1 reference

A novel expression cassette of lyssavirus shows that the distantly related Mokola virus can rescue a defective rabies virus genome

21 January 2018

1 reference

An improved method for recovering rabies virus from cloned cDNA.

21 January 2018

1 reference

Antigenic differences among Newcastle disease virus strains of different genotypes used in vaccine formulation affect viral shedding after a virulent challenge

21 January 2018

1 reference

A vaccine candidate of attenuated genotype VII Newcastle disease virus generated by reverse genetics

21 January 2018

1 reference

Generation by reverse genetics of an effective, stable, live-attenuated newcastle disease virus vaccine based on a currently circulating, highly virulent Indonesian strain

21 January 2018

1 reference

Generation by reverse genetics of an effective attenuated Newcastle disease virus vaccine based on a prevalent highly virulent Chinese strain.

21 January 2018

1 reference

Generation and evaluation of a recombinant genotype VII Newcastle disease virus expressing VP3 protein of Goose parvovirus as a bivalent vaccine in goslings

21 January 2018

1 reference

Generation of a recombinant chimeric Newcastle disease virus vaccine that allows serological differentiation between vaccinated and infected animals

21 January 2018

1 reference

Use of reverse genetics to enhance the oncolytic properties of Newcastle disease virus

21 January 2018

1 reference

Modified Newcastle disease virus vectors expressing the H5 hemagglutinin induce enhanced protection against highly pathogenic H5N1 avian influenza virus in chickens

21 January 2018

1 reference

Roles of the fusion and hemagglutinin-neuraminidase proteins in replication, tropism, and pathogenicity of avian paramyxoviruses

21 January 2018

1 reference

Avian paramyxovirus serotypes 2-9 (APMV-2-9) vary in the ability to induce protective immunity in chickens against challenge with virulent Newcastle disease virus (APMV-1).

21 January 2018

1 reference

Experimental infection of hamsters with avian paramyxovirus serotypes 1 to 9.

21 January 2018

1 reference

Avian paramyoxvirus-8 immunization reduces viral shedding after homologous APMV-8 challenge but fails to protect against Newcastle disease

21 January 2018

1 reference

Chimeric newcastle disease virus protects chickens against avian influenza in the presence of maternally derived NDV immunity

21 January 2018

1 reference

Paramyxovirus replication and pathogenesis. Reverse genetics transforms understanding

21 January 2018

1 reference

Recombinant Newcastle disease virus as a viral vector: effect of genomic location of foreign gene on gene expression and virus replication

21 January 2018

1 reference

Recombinant newcastle disease virus expressing a foreign viral antigen is attenuated and highly immunogenic in primates

21 January 2018

1 reference

High-level expression of a foreign gene from the most 3'-proximal locus of a recombinant Newcastle disease virus

21 January 2018

1 reference

Recovery of infectious SV5 from cloned DNA and expression of a foreign gene

21 January 2018

1 reference

Role of intergenic sequences in newcastle disease virus RNA transcription and pathogenesis

21 January 2018

1 reference

P and M gene junction is the optimal insertion site in Newcastle disease virus vaccine vector for foreign gene expression.

21 January 2018

1 reference

Development of a novel thermostable Newcastle disease virus vaccine vector for expression of a heterologous gene.

21 January 2018

1 reference

Autologous tumor vaccine modified with recombinant new castle disease virus expressing IL-7 promotes antitumor immune response

21 January 2018

1 reference

Nonsegmented negative-strand viruses as vaccine vectors

21 January 2018

1 reference

Phylogenetic analysis reveals a low rate of homologous recombination in negative-sense RNA viruses

21 January 2018

1 reference

Artificial recombination may influence the evolutionary analysis of Newcastle disease virus

21 January 2018

1 reference

Current perspectives in transfusion-transmitted infectious diseases: emerging and re-emerging infections

21 January 2018

1 reference

Recombinant vaccines against the mononegaviruses--what we have learned from animal disease controls

21 January 2018

1 reference

NEWCASTLE DISEASE VIRUS AS AN ANTINEOPLASTIC AGENT.

21 January 2018

1 reference

Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus

21 January 2018

1 reference

Efficiency of adjuvant active specific immunization with Newcastle disease virus modified tumor cells in colorectal cancer patients following resection of liver metastases: results of a prospective randomized trial

21 January 2018

1 reference

Prostate-specific antigen-retargeted recombinant newcastle disease virus for prostate cancer virotherapy

21 January 2018

1 reference

HIV transmission in a state prison system, 1988-2005.

21 January 2018

1 reference

Enhanced cellular immune responses to SIV Gag by immunization with influenza and vaccinia virus recombinants

21 January 2018

1 reference

HIV-1 evolution in gag and env is highly correlated but exhibits different relationships with viral load and the immune response

21 January 2018

1 reference

Induction of cellular immune responses to simian immunodeficiency virus gag by two recombinant negative-strand RNA virus vectors

21 January 2018

1 reference

Optimization of human immunodeficiency virus gag expression by newcastle disease virus vectors for the induction of potent immune responses

21 January 2018

1 reference

Newcastle disease virus expressing human immunodeficiency virus type 1 envelope glycoprotein induces strong mucosal and serum antibody responses in Guinea pigs

21 January 2018

1 reference

Retracted: Comparative Immunogenicity of HIV-1 gp160, gp140 and gp120 Expressed by Live Attenuated Newcastle Disease Virus Vector

21 January 2018

1 reference

Evaluation of humoral, mucosal, and cellular immune responses following co-immunization of HIV-1 Gag and Env proteins expressed by Newcastle disease virus

21 January 2018

1 reference

Newcastle disease virus, a host range-restricted virus, as a vaccine vector for intranasal immunization against emerging pathogens

21 January 2018

1 reference

Ebola crisis of 2014: are current strategies enough to meet the long-run challenges ahead?

21 January 2018

1 reference

Respiratory tract immunization of non-human primates with a Newcastle disease virus-vectored vaccine candidate against Ebola virus elicits a neutralizing antibody response

21 January 2018

1 reference

Recombinant Newcastle Disease virus capsids displaying enterovirus 71 VP1 fragment induce a strong immune response in rabbits

21 January 2018

1 reference

Protection against respiratory syncytial virus by a recombinant Newcastle disease virus vector

21 January 2018

1 reference

Newcastle disease virus-vectored Nipah encephalitis vaccines induce B and T cell responses in mice and long-lasting neutralizing antibodies in pigs

21 January 2018

1 reference

Rift Valley fever virus immunity provided by a paramyxovirus vaccine vector

21 January 2018

1 reference

Newcastle disease virus vector producing human norovirus-like particles induces serum, cellular, and mucosal immune responses in mice

21 January 2018

1 reference

The global one health paradigm: challenges and opportunities for tackling infectious diseases at the human, animal, and environment interface in low-resource settings

21 January 2018

1 reference

Assessing the risk of highly pathogenic avian influenza H5N1 transmission through poultry movements in Bali, Indonesia

21 January 2018

1 reference

Highly pathogenic avian influenza virus subtype H5N1 escaping neutralization: more than HA variation

21 January 2018

1 reference

Variation in protection of four divergent avian influenza virus vaccine seed strains against eight clade 2.2.1 and 2.2.1.1. Egyptian H5N1 high pathogenicity variants in poultry

21 January 2018

1 reference

Highly pathogenic H5N1 avian influenza virus: cause of the next pandemic?

21 January 2018

1 reference

Newcastle disease virus expressing H5 hemagglutinin gene protects chickens against Newcastle disease and avian influenza

21 January 2018

1 reference

Newcastle disease virus-based live attenuated vaccine completely protects chickens and mice from lethal challenge of homologous and heterologous H5N1 avian influenza viruses.

21 January 2018

1 reference

Immunization of primates with a Newcastle disease virus-vectored vaccine via the respiratory tract induces a high titer of serum neutralizing antibodies against highly pathogenic avian influenza virus.

21 January 2018

1 reference

Level of protection of chickens against highly pathogenic H5 avian influenza virus with Newcastle disease virus based live attenuated vector vaccine depends on homology of H5 sequence between vaccine and challenge virus

21 January 2018

1 reference

Newcastle disease virus-vectored vaccines expressing the hemagglutinin or neuraminidase protein of H5N1 highly pathogenic avian influenza virus protect against virus challenge in monkeys.

21 January 2018

1 reference

Immune responses and protection against H5N1 highly pathogenic avian influenza virus induced by the Newcastle disease virus H5 vaccine in ducks

21 January 2018

1 reference

Recombinant Paramyxovirus Type 1-Avian Influenza-H7 Virus as a Vaccine for Protection of Chickens Against Influenza and Newcastle Disease

21 January 2018

1 reference

Vaccination with Newcastle disease virus vectored vaccine protects chickens against highly pathogenic H7 avian influenza virus

21 January 2018

1 reference

Analysis of the early immune response to infection by infectious bursal disease virus in chickens differing in their resistance to the disease

21 January 2018

1 reference

Development of a tailored vaccine against challenge with very virulent infectious bursal disease virus of chickens using reverse genetics

21 January 2018

1 reference

A recombinant Newcastle disease virus (NDV) expressing VP2 protein of infectious bursal disease virus (IBDV) protects against NDV and IBDV.

21 January 2018

1 reference

A recombinant Newcastle disease virus (NDV) expressing infectious laryngotracheitis virus (ILTV) surface glycoprotein D protects against highly virulent ILTV and NDV challenges in chickens

21 January 2018

1 reference

Newcastle disease virus (NDV) recombinants expressing infectious laryngotracheitis virus (ILTV) glycoproteins gB and gD protect chickens against ILTV and NDV challenges.

21 January 2018

1 reference

Immunization of cattle with recombinant Newcastle disease virus expressing bovine herpesvirus-1 (BHV-1) glycoprotein D induces mucosal and serum antibody responses and provides partial protection against BHV-1.

21 January 2018

1 reference

Newcastle disease virus-vectored rabies vaccine is safe, highly immunogenic, and provides long-lasting protection in dogs and cats

21 January 2018

1 reference

Intramuscular inoculation of calves with an experimental Newcastle disease virus-based vector vaccine elicits neutralizing antibodies against Rift Valley fever virus

21 January 2018

1 reference

Delivery to the lower respiratory tract is required for effective immunization with Newcastle disease virus-vectored vaccines intended for humans

21 January 2018

1 reference

Elucidating the role of T cells in protection against and pathogenesis of dengue virus infections

21 January 2018

1 reference

New challenges in modern vaccinology

21 January 2018

1 reference

Preparation and efficacy of a live newcastle disease virus vaccine encapsulated in chitosan nanoparticles

21 January 2018

1 reference

Preparation and efficacy of Newcastle disease virus DNA vaccine encapsulated in PLGA nanoparticles

21 January 2018

1 reference

Newcastle disease virus vaccine encapsulated in biodegradable nanoparticles for mucosal delivery of a human vaccine.

21 January 2018

1 reference

Preparation and efficacy of Newcastle disease virus DNA vaccine encapsulated in chitosan nanoparticles.

21 January 2018

1 reference

Comparison of Heterologous Prime-Boost Strategies against Human Immunodeficiency Virus Type 1 Gag Using Negative Stranded RNA Viruses

21 January 2018

1 reference

The interface of animal and human vaccines

21 January 2018

1 reference

Consensus and Ancestral State HIV Vaccines

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/FMB.15.59

1 reference

4 September 2017

1 reference